Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents.

Papa, Alfredo

Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents. [electronic resource] - Journal of Crohn's & colitis Mar 2013 - 113-9 p. digital

Publication Type: Journal Article

1876-4479

10.1016/j.crohns.2012.03.001 doi


Adalimumab
Adolescent
Adult
Age Factors
Analysis of Variance
Anti-Inflammatory Agents, Non-Steroidal--therapeutic use
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized--therapeutic use
Colitis, Ulcerative--diagnosis
Crohn Disease--diagnosis
DNA, Viral--blood
Female
Hepacivirus--immunology
Hepatitis B Antibodies--blood
Hepatitis B Surface Antigens--blood
Hepatitis B Vaccines
Hepatitis B virus--immunology
Hepatitis B, Chronic--epidemiology
Hepatitis C Antibodies--blood
Hepatitis C, Chronic--epidemiology
Humans
Infliximab
Male
Middle Aged
Prevalence
RNA, Viral--blood
ROC Curve
Time Factors
Tumor Necrosis Factor-alpha--antagonists & inhibitors
Young Adult